Dr Katims on the Utility of the MSK-ACCESS Assay in Node+ MIBC
Andrew Katims, MD, MPH, discusses the utility of a circulating tumor DNA assay (MSK-ACCESS) in patients with node-positive muscle-invasive bladder cancer.
Andrew Katims Memorial Sloan Kettering Cancer Center Circulating Tumor Dna Assay Msk Access Patients With Node Positive Muscle Invasive Bladder Cancer 2023 Aua Annual Meeting
Source: onclive.com